Efficacy and reliability of Folixir products have been approved by clinical and in-vitro tests.
It was approved that the regular use of Folixir helps;

• Stop hair loss in 3 months,
• Start new and healthy hair re-growth in 6 months

* Clinical study was performed by using Folixir set of products for 6 months daily. Folixir set is composed of serum, tablet, shampoo and thickening conditioner.

The efficacy and reliability tests performed on Folixir products are as follows:

1) PHASE 0 (Pre-clinical Study Phase)
This phase includes in-vitro efficacy and cytotoxicity tests. On behalf of Folixir, tests in this phase were conducted by the world-renowned accredited BioAlternatives - State of the Art Laboratory in France. It was approved that Folixir Intensive Anti Hair Loss Therapy Serum locally inhibits DHT formation on hair follicles and has a Finasterid-like effect. Additionally, while inhibiting DHT formation, Folixir serum does not cause cytotoxicity.

2) PHASE 1

This phase includes tests performed on a tiny amount of "healthy" subjects. The number of volunteers are between 15 and 20. In this phase, pharmacokinetics, such as absorption, half-life and metabolism, are measured and side effects are observed - if any. Since Phase 1 is performed on "healthy" subjects, therapeutic efficacy is not observed in this phase. In Phase 1 study conducted at Novatemed Innoceuticals Labs, it was approved that Folixir products have no systemic side effects.

3) PHASE 2

This phase includes test performed on generally 30 - 50 subject that are affected by hair loss. Generally, 30 subjects are adequate for reliable results. Efficacy of the test compound can be observed after the tests. For Folixir products, this test was conducted at Novatemed Innoceuticals Labs on 42 subjects that are affected by hair loss. At the end of 6th month, hair loss stopped for 100% of the subjects and new and healthy hair growth generated for 92% of the subjects.

4) PHASE 3

This phase is conducted after the product is on the market. In this test, additional effects and therapeutic benefits of the products can be discovered. Folixir products are currently at this phase and up to now, it was observed that Folixir products are also very effective on treating Alopecia Areata, Total Alopecia and Telogen Effluvium - in addition to Androgenetic Alopecia.

IN-VITRO TEST RESULTS

French accredited laboratories have approved that Folixir products inhibit the main cause of Androgenetic Alopecia - DHT formation in hair follicles - very strongly and without any cellular damage.

It was also approved that Folixir Intensive Anti Hair Loss Therapy Serum inhibits DHT formation locally with no side effects or cytotoxicity.